Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
30 April 2024 - P3546
Humanised serum concentrations of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam against carbapenem-resistant Enterobacter cloacae
Thomas Lavoie, Katie Daffinee, Jason M. Pogue, Brahim Achour, Kerry Laplante,
30 April 2024 - O1174
Time to clinical response among patients treated with ceftazidime-avibactam vs ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)
Ryan K. Shields, Lilian Abbo, Renee Ackley, Samuel L. Aitken, Benjamin Albrecht, Ahmed Babiker, Esther Bae, Renzo Cifuentes, Kimberly Claeys, Brooke Curry, Kathryn Desear, Jason Gallagher, Eric Gregory, Alan Gross, Emily L. Heil, Carissa Hickey, Trieu-Vi Khuu, Megan Klatt, Ellen G. Kline, Ryan C. Kubat, Wesley D. Kufel, Jae Hyoung Lee, Ahmi Lim, Theresa Lingg, Conan Macdougall, Amy Mathers, Erin K. Mccreary, Marguerite Monogue, William Justin Moore, Shannon Olson, Jessica Oxer, Jeffrey C. Pearson, Christine Pham, Paulette Pinargote-Cornejo, Christopher Polk, Michael Satlin, Sarah Satola, Sunish Shah, Yash B. Solanki, Pranita Tamma, David Van Duin, Mollie Vannatta, Ana Vega, Veena Venugopalan, Michael Veve, Walaiporn Wangchinda, Lucy S. Witt, Janet Wu, Jason M. Pogue
29 April 2024 - P1826
Impact of colistin MIC on outcomes: results from the OVERCOME trial comparing colistin monotherapy and colistin + meropenem combination therapy
Jason M. Pogue, Michael Rybak, Navaneeth Narayanan, Varduhi Ghazyaran, Keith Kaye
28 April 2024 - P2533
Colistin/meropenem: the impact of synergy on outcomes in the OVERCOME trial
Mariya Huralska, Jason M. Pogue, Hamadullah Shaikh, Michael Rybak, Varduhi Ghazaryan, Keith Kaye
28 April 2024 - P2528
Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled data from two pivotal Phase 3 studies
Keith Kaye, Jason M. Pogue, Jeremy Dennison, Caroline Perry, Chun Huang, Meghan E. Luck, Aruni Mulgirigama, Salim Janmohamed, Amanda J. Sheets
28 April 2024 - P2587
Jabs to tabs goes global: point-prevalence of doses of intravenous antibiotic administered as a function of daily census
Abi Jenkins, Syed Gilani, Corrine Ashton, Ryan Hamilton, Sadiya Hussain, Stephen Hughes, Tina M. Khadern, Caley Yakemowicz, Jason M. Pogue, Erin K. Mccreary
28 April 2024 - P2536
Efficacy of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS) among immunocompromised patients
Ryan K. Shields, Lilian Abbo, Renee Ackley, Samuel L. Aitken, Benjamin Albrecht, Ahmed Babiker, Esther Bae, Renzo Cifuentes, Kimberly Claeys, Brooke Curry, Kathryn Desear, Jason Gallagher, Eric Gregory, Alan Gross, Emily L. Heil, Carissa Hickey, Trieu-Vi Khuu, Megan Klatt, Ellen G. Kline, Ryan Kubat, Wesley D. Kufel, Jae Hyoung Lee, Ahmi Lim, Theresa Lingg, Conan Macdougall, Amy Mathers, Erin K. Mccreary, Marguerite Monogue, William Justin Moore, Shannon Olson, Jessica Oxer, Jeffrey C. Pearson, Christine Pham, Paulette Pinargote-Cornejo, Christopher Polk, Michael Satlin, Sarah Satola, Sunish Shah, Yash B. Solanki, Pranita Tamma, David Van Duin, Mollie Vannatta, Ana Vega, Veena Venugopalan, Michael Veve, Walaiporn Wangchinda, Lucy S. Witt, Janet Wu, Jason M. Pogue
23 April 2022 - P1391
Efficacy of cefiderocol in patients with nosocomial pneumonia and complicated urinary tract infections caused by Enterobacterales and carbapenem-resistant Enterobacterales (CREs) from three randomised clinical trials
Thierry Naas, Jason M Pogue, Keith S Kaye, Takamichi Baba, Anju Menon, Roger Echols, Yoshinori Yamano, Christopher Longshaw, Simon Portsmouth
11 July 2021 - 4773
Results from the OVERCOME trial: colistin monotherapy versus combination therapy for the treatment of pneumonia or bloodstream infection due to extensively drug-resistant Gram-negative bacilli
Keith S. Kaye, K.S. Kaye (1), D. Marchaim (2), V. Thamlikitkul (3), Y. Carmeli (4), C.H. Chiu (5), G. Daikos (6), S. Dhar (7), E. Durante-Mangoni (8), A. Gikas (9), A. Kotanidou (10), M. Paul (11), E. Roilides (12), M. Rybak (13), M. Samarkos (14), M. Sims (15), D. Tancheva (16), S. Tsiodros (17), G. Divine (18), V. Ghazyaran (19), J. Pogue (20)
09 July 2021 - 2653
Comparative in vitro activity of ceftolozane/tazobactam, ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, and cefiderocol against Pseudomonas aeruginosa, including drug-resistant isolates at an academic medical centre
Megan Klatt, M. Klatt (1, 2), N. Dillman (1), G. Eschenauer (1, T. Gandhi (3), V. Marshall (1), J. Nagel (1), T. Patel (1), L. Petty (3), A. Smith (4), J. Pogue (2)
09 July 2021 - 1228
Rethinking optimisation of empiric Gram-negative therapy for pneumonia in intensive care units: we can do better
Megan Klatt, M. Klatt (1, 2), N. Dillman (1), G. Eschenauer (1, T. Gandhi (3), V. Marshall (1), J. Nagel (1), T. Patel (1), L. Petty (3), A. Smith (4), J. Pogue (2)
2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Pharmacotherapy; doi: 10.1002/phar.2209.
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, Mical Paul, George L Daikos, Alan Forrest, Daniele R Giacobbe, Claudio Viscoli, Helen Giamarellou, Ilias Karaiskos, Donald Kaye, Johan W Mouton, Vincent H Tam, Visanu Thamlikitkul, Richard G Wunderink, Jian Li, Roger L Nation, Keith S Kaye
15 April 2019 - P1871
Comparative activity of plazomicin and conventional aminoglycosides using current CLSI/EUCAST and proposed USCAST breakpoints against carbapenem-resistant Enterobacteriaceae in Detroit, Michigan
Jason Pogue, Maureen Taylor, Ryan Mynatt, Robert Mitchell, Sorabh Dhar, Hossein Salimnia
15 April 2019 - P1807
Do we have any clue of what we are doing to optimise empiric therapy? The Pseudomonas aeruginosa example
Jason Pogue, Vincent Marshall, Aaron Smith, Carol Young, Paul Lephart, Keith S. Kaye, Twisha S. Patel
13 April 2019 - P0463
Clinical implications of microbiologic treatment failure in pneumonia: the pathogen matters
Owen Albin, Twisha S. Patel, Oryan Henig, John P. Mills, Jason Pogue, Lindsay Petty, Thomas Valley, Keith S. Kaye
24 April 2018 - P2427
In vitro antimicrobial activity of ceftolozane-tazobactam against real world clinical isolates of non-fermenting Gram-negative bacilli at a large academic tertiary care hospital
Twisha S. Patel, T. Patel, K. Kaye, P. Lephart, M. Bachman, A. Smith, V. Marshall, J. Pogue, J. Mills
23 April 2018 - O0740
Real world clinical experience with ceftolozane/tazobactam (C/T) for the treatment of complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) due to Pseudomonas aeruginosa (PSA): an electronic medical record database
Laura Puzniak, J. Pogue, R. Sanagaram, S. Merchant, P. Raina, L. Puzniak
23 April 2018 - P1684
Translating polymyxin B (PolyB) and meropenem synergy against carbapenem-resistant Acinetobacter baumannii (CRAB): moving toward a rational, combinatorial pharmacokinetic target
Nicholas Smith, N. Smith, E. Lakota, J. Lenhard, J. Bulitta, K. Mergenhagen, J. Pogue, K. Kaye, R. Nation, J. Li, A. Forrest, B. Tsuji
22 April 2018 - P0880
Review of factors influencing antibiotic prescribing, 2012-2017
Jason Pogue, M. Coppry, A. Rogues, C. Dumartin
22 April 2018 - P1042
Comparative activity of meropenem/vaborbactam (MV) and ceftazidime/avibactam (CA) against carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical specimens at the Detroit Medical Center (DMC)
Hossein Salimnia, J. Pogue, P. Lephart, M. Taylor, R. Mitchell, M. Fairfax, H. Salimnia
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.